Skip to main content
SpringerLink
Log in

Cyclosporin A in insulin-dependent diabetes

  • Chapter
Cyclosporin

  • 96 Accesses

Abstract

More than 500 recent-onset diabetics have been treated with cyclosporine A (CsA) in an attempt to induce remission of the disease. All published reports have shown a favourable effect but problems persist which still preclude large-scale use of this new clinical application of CsA. In this article we shall review the main features of the use of CsA in experimental and clinical diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Laupacis, A., Gardell, C., Dupré, J-, Stiller, C R., Keown, P., Wallace, A. C. and Thibert, P. (1983) Cyclosporin prevents diabetes in BB Wistar rats. Lancet, 1, 10–12

    Article  PubMed  CAS  Google Scholar 

  2. Mori, Y., Suko, M., Odudaira, M., Matsuba, I., Tsuruoka, A., Sasaki, A., Yokoyama, M., Tanase, T., Shida, T., Nishimura, M., Terada, E. and Ykeda, Y. (1986) Preventive effects of cyclosporin on diabetes in NOD mice. Diabetohgia, 29, 244–247

    Article  CAS  Google Scholar 

  3. Like, A. A., Dirodi, V., Thomas, S., Guberski, D. L. and Rossini, A. A. (1984) Prevention of diabetes mellitus in the BB/W rat with cyclosporin A. Am. J. Pathol., 117, 92–97

    PubMed  CAS  Google Scholar 

  4. Boitard, C. and Bach, J. F. (1986) Experimental models of type I diabetes. Pathol. Immunopathol. Res., 5, 384–415

    Article  PubMed  Google Scholar 

  5. Stiller, C. R., Dupré, J., Gent, M., Jenner, M. R., Keown, P. A., Laupacis, A., Martell, R., Rodger, N. W., Granffenried, B. V. and Wole, B. M. J. (1984) Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science, 223, 1362–1367

    Article  PubMed  CAS  Google Scholar 

  6. Assan, R., Feutren, G., Debray-Sachs, M., Quiniou-debrie, M. C., Laborie, C., Thomas, G., Chatenoud, L. and Bach, J. F. (1985) Metabolic and immunological effects of cyclosporin in recently diagnosed type I diabetes mellitus. Lancet, 1, 67–71

    Article  PubMed  CAS  Google Scholar 

  7. Feutren, G., Papoz, L., Assan, R., Vialettes, B., Karsenty, G., Vexiau, P., Du Rostu, H., Rodier, M., Sirmai, J., Lallemand, A. and Bach, J. F. (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Lancet, 1, 119–123

    Article  Google Scholar 

  8. Canadian—European Diabetes Study Group (1988) Cyclosporin-induced remission of IDDM after early intervention: association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes, 37, 1574–1582

    Article  Google Scholar 

  9. Bougnères, P. H., Carel, J. C., Castano, L., Boitard, C., Gardin, J. P., Landais, P., Hors, J., Mihatsch, M. J. and Paillard, M. (1988) Factors determining early remission of type 1 diabetes in children treated with cyclosporin A. N. Engl J. Med., 318, 663–670

    Article  PubMed  Google Scholar 

  10. Gotfredsen, G. F., Buschard, K. and Frandsen, E. K. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabeiohgia, 28, 933–935

    CAS  Google Scholar 

  11. Shah, S. C., Malone, J. I. and Simpson, N. E. (1989) A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N. Engl J. Med., 320, 550–554

    Article  PubMed  CAS  Google Scholar 

  12. Wang, Y., McDuffie, M., Nomikos, I. N., Hao, L. and Lafferty, K. J. (1988) Effect of cyclosporine in immunologically mediated diabetes in nonobese diabetic mice. Transplantation, 46, 101S–106S (Suppl. 5).

    PubMed  Google Scholar 

  13. Mountz, J. D., Smith, H. R., Wilder, R. L., Reeves, J. P. and Steinberg, A. D. (1987) CsA therapy in MRL-lp/lpr mice: amelioration of immunopathology despite autoantibody production. J. Immunol., 138, 157–163

    PubMed  CAS  Google Scholar 

  14. Feutren, G., Querin, S., Noel, L. H., Chatenoud, L., Beaurain, G., Tron, F., Lesavre, P. and Bach, J. F. (1987) Effects of cyclosporine in severe systemic lupus. J. Pediatr., 111, 1063–168

    Article  PubMed  CAS  Google Scholar 

  15. Dupré, J., Stiller, C. R., Gent, M., Dormer, A., Von Graffenreid, B., Murphy, G., Heinrichs, D., Jeriner, M. R., Keown, P. A., Laupacis, A., Mahon, J., Martell, R., Rodger, N. W. and Wolfe, B. W. (1988) Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months. Transplant. Proc., 20, 184–192

    PubMed  Google Scholar 

  16. Molvig, J., Mandrup-Poulson, T., Andersen, H. U., Spinas, G. A., Helqvist, S. and Munck, M. (1988) Ciclosporin immunotherapy in Type 1 (insulin-dependent) diabetes: importance of HLA-DR phenotype for the clinical and immunological response (abstract). In: Abstracts Meeting Immunomoduhtion in Autoimmune Disease, Paris, June 1988

    Google Scholar 

  17. Hors, J., Papoz, L., Eschwege, E., Vexiau, P., Geutren, G., Boitard, C. and Bach, J. F. (1988) HLA and responsiveness to cyclosporin A in treated IDD patients (abstract). In: Abstracts Meeting Immunomoduhtion in Autoimmune Disease, Paris, June 1988

    Google Scholar 

  18. Boitard, C., Feutren, G., Castano, L., Debray-Sachs, M., Assan, R., Hors, J. and Bach, J. F. (1987) The effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients. J. Clin. Invest., 80, 1607–1612

    Article  PubMed  CAS  Google Scholar 

  19. Debray-Sachs, M., Sai, P., Feutren, G., Lang, F., Maugendre, D., Boitard, C., Hors, J. and Bach, J. F. (1988) Inhibition of insulin release in vitro mediated by mononuclear cells from cyclosporin A or placebo treated diabetic patients. Diabetes, 37, 873–877

    Article  PubMed  CAS  Google Scholar 

  20. Bach, J. F. (1988) Mechanisms of autoimmunity in insulin-dependent diabetes mellitus. Clin. Exp. Immunol., 72, 1–8

    PubMed  CAS  Google Scholar 

  21. Chatenoud, L., Feutren, G., Nelson, D. L., Boitard, C., Charron, D. J. and Bach, J. F. (1988) T cell mediated immunity in insulin dependent diabetic patients: effect of cyclosporin. Diabetes (In press)

    Google Scholar 

  22. Caillat-Zucman, S., Chatenoud, L. and Bach, J. F. (1988) Differential in vitro and in vivo action of cyclosporin A on the induction of IL-2 receptor α and β chains. Clin. Exp. Immunol. (in press)

    Google Scholar 

  23. Chatenoud, L., Dugas, B., Damais, C. and Bach, J. F. (1988) In vivo cyclosporine A treatment inhibits spleen cell mitogen-fcriggered free (Ca2 +) increase. Transplant. Proc., 20, 170–172

    PubMed  CAS  Google Scholar 

  24. Feutren, G. (1988) Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in Type I diabetes trials. Transplant. Proc., 20, 356–366

    PubMed  CAS  Google Scholar 

  25. Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W. Jr., Atchinson, R. W., Nalesnik, M. A., Ho, M., Griffith, B. P., Hakala, T. R., Hardesty, R. L. and Jaffe, R. (1984) Reversibility of lymphomas and lympho-proliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1, 583–587

    Article  PubMed  CAS  Google Scholar 

  26. Mahon, J. L., Gurun, H. C., Stobie, K., Gibson, C., Garcia, B., Dupré, J. and Stiller, C. R. (1988) The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats. Transplant. Proc., 20, 197–200

    PubMed  CAS  Google Scholar 

  27. Assan, R., Feutren, G. and Sirmai, J. (1988) Cyclosporine trials in diabetes: updated results of the French experience. Transplant. Proc., 20, 178–183

    PubMed  CAS  Google Scholar 

  28. Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K. and Fathman, C. G. (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science, 240, 659–661

    Article  PubMed  CAS  Google Scholar 

  29. Chatenoud, L., Ferran, C., Reuter, A., Franchimont, P., Legendre, C., Kreis, H. and Bach, J. F. (1988) Clinical use of OKT3: the role of cytokine release and xenosensitization. J. Autoimmunity, 1, 631–640

    Article  Google Scholar 

Download references

Authors
  1. Jean-François Bach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Immunopathology Laboratory, Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, AB9 2ZD, Scotland

    Angus W. Thomson BSc(Hons), MSc, PhD, DSc, MRCPath, FIBiol (Reader in Immunology) (Reader in Immunology)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bach, JF. (1989). Cyclosporin A in insulin-dependent diabetes. In: Thomson, A.W. (eds) Cyclosporin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0859-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0859-8_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6874-1

  • Online ISBN: 978-94-009-0859-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation